Debate – From SYNTAX to FREEDOM and STICH: PCI Is Moving to Centre Stage
Abstract
Introduction
Multivessel coronary artery disease
Left main coronary artery disease
Ischaemic cardiomyopathy and diabetes
Conclusions
Disclosure statement
References
- Head, S.J.; Kaul, S.; Mack, M.J.; et al. The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease. Eur Heart J 2013, 34, 2510–2518. [Google Scholar] [CrossRef] [PubMed]
- Stergiopoulos, K.; Boden, W.E.; Hartigan, P.; et al. Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials. JAMA Intern Med 2014, 174, 232–240. [Google Scholar] [CrossRef] [PubMed]
- Windecker, S.; Stortecky, S.; Stefanini, G.G.; et al. Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ 2014, 348, g3859. [Google Scholar] [CrossRef] [PubMed]
- Weintraub, W.S.; Grau-Sepulveda, M.V.; Weiss, J.M.; et al. Comparative effectiveness of revascularization strategies. N Engl J Med 2012, 366, 1467–1476. [Google Scholar] [CrossRef]
- Serruys, P.W.; Morice, M.C.; Kappetein, A.P.; et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009, 360, 961–972. [Google Scholar] [CrossRef]
- Park, S.J.; Kim, Y.H.; Park, D.W.; et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med 2011, 364, 1718–1727. [Google Scholar] [CrossRef]
- Boudriot, E.; Thiele, H.; Walther, T.; et al. Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis. J Am Coll Cardiol 2011, 57, 538–545. [Google Scholar] [CrossRef]
- Farkouh, M.E.; Domanski, M.; Sleeper, L.A.; et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 2012, 367, 2375–2384. [Google Scholar] [CrossRef]
- Mohr, F.W.; Morice, M.C.; Kappetein, A.P.; et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013, 381, 629–638. [Google Scholar] [CrossRef]
- Farooq, V.; van Klaveren, D.; Steyerberg, E.W.; et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 2013, 381, 639–650. [Google Scholar] [CrossRef]
- Park, S.J.; Ahn, J.M.; Kim, Y.H.; et al. Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J Med 2015, 372, 1204–1212. [Google Scholar] [CrossRef]
- Chang, M.; Ahn, J.M.; Lee, C.W.; et al. Long-Term Mortality Aher Coronary Revascularization in Nondiabetic Patients With Multivessel Disease. J Am Coll Cardiol 2016, 68, 29–36. [Google Scholar] [CrossRef]
- Bangalore, S.; Guo, Y.; Samadashvili, Z.; Blecker, S.; Xu, J.; Hannan, E.L. Everolimus-eluting stents or bypass surgery for multivessel coronary disease. N Engl J Med 2015, 372, 1213–1222. [Google Scholar] [CrossRef]
- Bangalore, S. Applicability of the COURAGE, BARI 2D, and FREEDOM Trials to Contemporary Practice. J Am Coll Cardiol 2016, 68, 996–998. [Google Scholar] [CrossRef]
- Bing, R.; Yong, A.S.; Lowe, H.C. Percutaneous Transcatheter Assessment of the Leh Main Coronary Artery: Current Status and Future Directions. JACC Cardiovasc Interv 2015, 8, 1529–1539. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Yusuf, S.; Zucker, D.; Peduzzi, P.; et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994, 344, 563–570. [Google Scholar] [CrossRef]
- Lee, P.H.; Ahn, J.M.; Chang, M.; et al. Leh Main Coronary Artery Disease: Secular Trends in Patient Characteristics, Treatments, and Outcomes. J Am Coll Cardiol 2016, 68, 1233–1246. [Google Scholar] [CrossRef] [PubMed]
- Morice, M.C.; Serruys, P.W.; Kappetein, A.P.; et al. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial. Circulation 2014, 129, 2388–2394. [Google Scholar] [CrossRef]
- Ahn, J.M.; Roh, J.H.; Kim, Y.H.; et al. Randomized Trial of Stents Versus Bypass Surgery for Leh Main Coronary Artery Disease: 5-Year Outcomes of the PRECOMBAT Study. J Am Coll Cardiol 2015, 65, 2198–206. [Google Scholar] [CrossRef] [PubMed]
- Stone, G.W.; Sabik, J.F.; Serruys, P.W.; et al. Everolimus-Eluting Stents or Bypass Surgery for Leh Main Coronary Artery Disease. N Engl J Med 2016, 375, 2223–2235. [Google Scholar] [CrossRef]
- Makikallio, T.; Holm, N.R.; Lindsay, M.; et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet 2016, 388, 2743–2752. [Google Scholar] [CrossRef] [PubMed]
- Velazquez, E.J.; Lee, K.L.; Jones, R.H.; et al. Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. N Engl J Med 2016, 374, 1511–1520. [Google Scholar] [CrossRef]
- Bangalore, S.; Guo, Y.; Samadashvili, Z.; Blecker, S.; Hannan, E.L. Revascularization in Patients With Multivessel Coronary Artery Disease and Severe Leh Ventricular Systolic Dysfunction: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery. Circulation 2016, 133, 2132–2140. [Google Scholar] [CrossRef]
- Piccolo, R.; Franzone, A.; Koskinas, K.C.; et al. Effect of Diabetes Mellitus on Frequency of Adverse Events in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. Am J Cardiol 2016, 118, 345–352. [Google Scholar] [CrossRef]
- Hakeem, A.; Garg, N.; Bhatti, S.; Rajpurohit, N.; Ahmed, Z.; Uretsky, B.F. Effectiveness of percutaneous coronary intervention with drug-eluting stents compared with bypass surgery in diabetics with multivessel coronary disease: comprehensive systematic review and meta-analysis of randomized clinical data. J Am Heart Assoc 2013, 2, e000354. [Google Scholar] [CrossRef]
- Windecker, S.; Kolh, P.; Alfonso, F.; et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014, 35, 2541–2619. [Google Scholar]
- Piccolo, R.; Giustino, G.; Mehran, R.; Windecker, S. Stable coronary artery disease: revascularisation and invasive strategies. Lancet 2015, 386, 702–713. [Google Scholar] [CrossRef] [PubMed]
- Athappan, G.; Chacko, P.; Patvardhan, E.; Gajulapalli, R.D.; Tuzcu, E.M.; Kapadia, S.R. Late stroke: comparison of percutaneous coronary intervention versus coronary artery bypass grafting in patients with multivessel disease and unprotected left main disease: a meta-analysis and review of literature. Stroke 2014, 45, 185–193. [Google Scholar] [CrossRef]
- Zimmermann, F.M.; De Bruyne, B.; Pijls, N.H.; et al. Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: a comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease. Am Heart J 2015, 170, 619–626. [Google Scholar]
- Windecker, S.; Piccolo, R. Myocardial Revascularization for Leh Main Coronary Artery Disease: A Step Toward Individualized Treatment Selection. J Am Coll Cardiol 2016, 68, 1010–1013. [Google Scholar] [CrossRef] [PubMed]
- Kaul, U.; Bangalore, S.; Seth, A.; et al. Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes. N Engl J Med 2015, 373, 1709–1719. [Google Scholar] [CrossRef] [PubMed]
© 2018 by the author. Attribution - Non-Commercial - NoDerivatives 4.0.
Share and Cite
Piccolo, R.; Windecker, S. Debate – From SYNTAX to FREEDOM and STICH: PCI Is Moving to Centre Stage. Cardiovasc. Med. 2018, 21, 61. https://doi.org/10.4414/cvm.2018.00546
Piccolo R, Windecker S. Debate – From SYNTAX to FREEDOM and STICH: PCI Is Moving to Centre Stage. Cardiovascular Medicine. 2018; 21(3):61. https://doi.org/10.4414/cvm.2018.00546
Chicago/Turabian StylePiccolo, Raffaele, and Stephan Windecker. 2018. "Debate – From SYNTAX to FREEDOM and STICH: PCI Is Moving to Centre Stage" Cardiovascular Medicine 21, no. 3: 61. https://doi.org/10.4414/cvm.2018.00546
APA StylePiccolo, R., & Windecker, S. (2018). Debate – From SYNTAX to FREEDOM and STICH: PCI Is Moving to Centre Stage. Cardiovascular Medicine, 21(3), 61. https://doi.org/10.4414/cvm.2018.00546